Q3 2020
Released Nov 10, 2020, before the open
10-Q filed Nov 10, 2020, 41 days after period end · 0001104659-20-123339
Q3 2020 · 10-Q
Revenue$0.00$0.00 −100.0% vs Q3 2019no prior Q2 2020 on file
Net Income-$4.31M-$4.31M N/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.07-$0.07 N/M vs Q3 2019N/M vs Q2 2020
Operating Income-$4,375,056N/M
Operating Cash Flowderived-$4,163,559N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $0.00 | $164.99K | $0.00 | $0.00 |
| Net Income | -$4.31M | -$3.06M | -$2.46M | -$4.70M |
| EPS Diluted | -$0.07 | -$0.12 | -$0.12 | -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR